World's Best Scientists 2026 revealed!
Kenneth C. Anderson

Kenneth C. Anderson

Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2026

D-Index & Metrics

Best Scientists

D-Index
230
Citations
222791
World Ranking
94
National Ranking
66

Medicine

D-Index
233
Citations
225287
World Ranking
56
National Ranking
43

Research.com Recognitions

  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award
  • 2012 - Warren Alpert Foundation Prize For the discovery, preclinical and clinical development of bortezomib to FDA approval and front line therapy for the treatment of patients with multiple myeloma.
  • 2010 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Kenneth C. Anderson is affiliated with Harvard University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with focused subfields including Molecular Biology, Hematology, Oncology, Immunology, and Pathology and Forensic Medicine.

The main topics Kenneth C. Anderson covers in their body of work encompass Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, CAR-T cell therapy research, Ubiquitin and proteasome pathways, Immunotherapy and Immune Responses, and Chronic Lymphocytic Leukemia Research.

Frequent collaborators in their research projects include:

  • Nikhil C. Munshi
  • Mehmet Samur
  • Paul G. Richardson
  • Yu-Tzu Tai
  • Mariateresa Fulciniti

The venues where Kenneth C. Anderson has regularly published work include:

  • Blood
  • Blood Advances
  • Blood Cancer Journal
  • Leukemia
  • Journal of Clinical Oncology

Recent papers featuring Kenneth C. Anderson's contributions are:

  • The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee, 2022, Blood
  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma, 2022, New England Journal of Medicine
  • A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma, 2020, Blood Advances
  • Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma, 2021, Nature Communications
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, 2021, The Lancet Oncology

Kenneth C. Anderson has received several awards acknowledging their work, including the Warren Alpert Foundation Prize in 2012 for discovery and clinical development related to bortezomib in multiple myeloma treatment; election as a Member of the National Academy of Medicine in 2010; and membership in the Association of American Physicians.

Best Publications

  • Multiple myeloma

    Noopur Raje;Kenneth C. Anderson

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • A phase 2 study of bortezomib in relapsed, refractory myeloma.

    Paul G. Richardson;Bart Barlogie;James Berenson;Seema Singhal

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

    Jake E. Delmore;Ghayas C. Issa;Madeleine E. Lemieux;Peter B. Rahl

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

    Jesús F. San Miguel;Rudolf Schlag;Nuriet K. Khuageva;Meletios A. Dimopoulos

  • The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

    Teru Hideshima;Paul Richardson;Dharminder Chauhan;Vito J. Palombella

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Initial genome sequencing and analysis of multiple myeloma

    Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis

  • Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo

  • Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

    Teru Hideshima;Dharminder Chauhan;Dharminder Chauhan;Yoshihito Shima;Yoshihito Shima;Noopur Raje;Noopur Raje

  • Lenalidomide after stem-cell transplantation for multiple myeloma

    Philip L. McCarthy;Kouros Owzar;Craig C. Hofmeister;David D. Hurd

  • Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

    Faith E. Davies;Noopur Raje;Noopur Raje;Noopur Raje;Teru Hideshima;Teru Hideshima;Teru Hideshima;Suzanne Lentzsch;Suzanne Lentzsch;Suzanne Lentzsch

  • High-throughput oncogene mutation profiling in human cancer

    Roman K. Thomas;Alissa C. Baker;Ralph M. DeBiasi;Ralph M. DeBiasi;Wendy Winckler;Wendy Winckler

  • NF-κB as a Therapeutic Target in Multiple Myeloma *

    Teru Hideshima;Dharminder Chauhan;Paul Richardson;Constantine Mitsiades

  • Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

    Michel Attal;Valerie Lauwers-Cances;Cyrille Hulin;Xavier Leleu

  • Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

    N Hamajima;K Hirose;K Tajima;T Rohan

Frequent Co-Authors

Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Paul G. Richardson
Paul G. Richardson Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Yu-Tzu Tai
Yu-Tzu Tai Harvard University
Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Noopur Raje
Noopur Raje Harvard University
Robert L. Schlossman
Robert L. Schlossman Harvard University
Steven P. Treon
Steven P. Treon Harvard University
Irene M. Ghobrial
Irene M. Ghobrial Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in pursuing healthcare careers, there are several flexible online pathways to consider beyond traditional medical school. Nursing remains one of the most popular and rewarding fields, and a variety of online programs can make career advancement more accessible and affordable.

If you already hold an RN license, exploring the cheapest rn to bsn online programs can help you complete your Bachelor of Science in Nursing at a lower cost and in less time. For aspiring nurses without a prior nursing degree, options like the cheapest direct entry msn programs and online bsn programs for non nurses provide alternative routes into the profession.

For those aiming for leadership roles, research, or teaching, advancing your education through online phd nursing programs can open doors to higher salaries and new opportunities. Whatever pathway you choose, online degrees offer flexibility and the ability to balance studies with other commitments.

Best Scientists Citing Kenneth C. Anderson

Trending Scientists

Recently Published Articles